Medpace Holdings, Inc. (MEDP): who owns it and who trades it
As of Nov 16, 2026, MEDP insiders reported 50 open-market sales worth $411M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was August J. Troendle (CEO), with $343M. 9 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Medpace Holdings
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns MEDP
695 funds and institutions reported MEDP shares worth $13.2B at the end of Q2 2026, about 87% of the company. The largest holder is BlackRock, Inc. with 8.7%.
Funds and institutions (13F) 87%Everyone else 13%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 2.50M | 8.75% | $1.3B | +1% |
| T. Rowe Price Associates | 2.07M | 7.25% | $1.1B | +615% |
| AQR Capital Management LLC | 1.28M | 4.48% | $677M | -6% |
| Vanguard Portfolio Management LLC | 1.13M | 3.97% | $600M | +1% |
| Vanguard Capital Management LLC | 1.03M | 3.60% | $544M | +2% |
| State Street Corp | 710,895 | 2.49% | $376M | +4% |
| Geode Capital Management, LLC | 710,465 | 2.49% | $376M | -5% |
| Wasatch Advisors LP | 636,595 | 2.23% | $337M | -18% |
| Invesco Ltd. | 579,241 | 2.03% | $307M | +0% |
| Baillie Gifford & Co | 473,211 | 1.66% | $251M | -6% |
| Arrowstreet Capital, Limited Partnership | 429,012 | 1.50% | $227M | +8% |
| Renaissance Technologies LLC | 415,588 | 1.46% | $220M | -18% |
| Dimensional Fund Advisors LP | 397,500 | 1.39% | $211M | +14% |
| Morgan Stanley | 317,548 | 1.11% | $168M | +10% |
| UBS Group AG | 303,926 | 1.06% | $161M | -11% |
| Bessemer Group Inc | 282,897 | 0.99% | $150M | -1% |
| Mawer Investment Management Ltd. | 267,175 | 0.94% | $141M | -40% |
| Epoch Investment Partners, Inc. | 266,547 | 0.93% | $141M | +89% |
| TD Asset Management Inc | 263,872 | 0.92% | $140M | +98% |
| Thrivent Financial for Lutherans | 256,341 | 0.90% | $136M | +11% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, MEDP insiders reported $0 of open-market purchases and $411M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Stephen P Ewald | General Counsel & Corp. | Sale | 1,245 | $690.00 | $859K | Form 4 |
| Oct 27, 2026 | Susan E Burwig | Vice president | Sale | 3,940 | $677.00 | $2.7M | Form 4 |
| Oct 26, 2026 | Susan E Burwig | Vice president | Sale | 16,060 | $677.00 | $10.9M | Form 4 |
| Sep 30, 2026 | August J. Troendle | CEO | Sale | 21,966 | $625.47 | $13.7M | Form 4 |
| Sep 29, 2026 | August J. Troendle | CEO | Sale | 26,701 | $621.02 | $16.6M | Form 4 |
| Sep 28, 2026 | August J. Troendle | CEO | Sale | 2,410 | $620.07 | $1.5M | Form 4 |
| Sep 25, 2026 | August J. Troendle | CEO | Sale | 154 | $620.60 | $95.6K | Form 4 |
| Sep 24, 2026 | August J. Troendle | CEO | Sale | 27,833 | $621.33 | $17.3M | Form 4 |
| Sep 23, 2026 | August J. Troendle | CEO | Sale | 16,083 | $628.64 | $10.1M | Form 4 |
| Sep 22, 2026 | August J. Troendle | CEO | Sale | 49,018 | $628.11 | $30.8M | Form 4 |
| Sep 21, 2026 | August J. Troendle | CEO | Sale | 21,883 | $623.29 | $13.6M | Form 4 |
| Sep 17, 2026 | August J. Troendle | CEO | Sale | 10,880 | $620.40 | $6.7M | Form 4 |
| Sep 16, 2026 | August J. Troendle | CEO | Sale | 8,770 | $621.29 | $5.4M | Form 4 |
| Sep 15, 2026 | August J. Troendle | CEO | Sale | 15,971 | $620.84 | $9.9M | Form 4 |
| Aug 27, 2026 | August J. Troendle | CEO | Sale | 650 | $620.27 | $403K | Form 4 |
| Aug 26, 2026 | Robert O. Kraft | Director | Sale | 3,858 | $617.81 | $2.4M | Form 4 |
| Aug 26, 2026 | August J. Troendle | CEO | Sale | 4,000 | $620.03 | $2.5M | Form 4 |
| Aug 25, 2026 | August J. Troendle | CEO | Sale | 673 | $620.38 | $418K | Form 4 |
| Aug 24, 2026 | August J. Troendle | CEO | Sale | 1,983 | $620.23 | $1.2M | Form 4 |
| Aug 21, 2026 | August J. Troendle | CEO | Sale | 13,995 | $624.45 | $8.7M | Form 4 |
| Aug 20, 2026 | Kevin M. Brady | CFO | Sale | 3,400 | $625.24 | $2.1M | Form 4 |
| Aug 20, 2026 | August J. Troendle | CEO | Sale | 27,174 | $618.79 | $16.8M | Form 4 |
| Aug 19, 2026 | August J. Troendle | CEO | Sale | 15,609 | $606.47 | $9.5M | Form 4 |
| Aug 19, 2026 | Brian T Carley | Director | Sale | 5,000 | $608.63 | $3M | Form 4 |
| Aug 19, 2026 | Fred B Davenport Jr | Director | Sale | 7,283 | $606.15 | $4.4M | Form 4 |
| Aug 13, 2026 | August J. Troendle | CEO | Sale | 458 | $600.39 | $275K | Form 4 |
| Aug 12, 2026 | August J. Troendle | CEO | Sale | 11,366 | $601.53 | $6.8M | Form 4 |
| Aug 11, 2026 | Cornelius P. McCarthy III | Director | Sale | 1,140 | $605.37 | $690K | Form 4 |
| Aug 11, 2026 | August J. Troendle | CEO | Sale | 17,610 | $605.11 | $10.7M | Form 4 |
| Aug 10, 2026 | August J. Troendle | CEO | Sale | 5,534 | $601.53 | $3.3M | Form 4 |
| Aug 7, 2026 | Cornelius P. McCarthy III | Director | Sale | 795 | $585.07 | $465K | Form 4 |
| Jul 28, 2026 | August J. Troendle | CEO | Sale | 3,510 | $600.01 | $2.1M | Form 4 |
| Jul 28, 2026 | Susan E Burwig | Vice president | Sale | 7,500 | $600.00 | $4.5M | Form 4 |
| Jul 27, 2026 | August J. Troendle | CEO | Sale | 3,728 | $600.85 | $2.2M | Form 4 |
| May 28, 2026 | Stephen P Ewald | General Counsel & Corp. | Sale | 16,349 | $450.00 | $7.4M | Form 4 |
| Mar 17, 2026 | Jesse J Geiger | President | Sale | 31,707 | $455.30 | $14.4M | Form 4 |
| Dec 3, 2025 | August J. Troendle | CEO | Sale | 668 | $590.69 | $395K | Form 4 |
| Dec 2, 2025 | August J. Troendle | CEO | Sale | 5,698 | $590.47 | $3.4M | Form 4 |
| Dec 1, 2025 | August J. Troendle | CEO | Sale | 23,178 | $593.25 | $13.8M | Form 4 |
| Nov 28, 2025 | August J. Troendle | CEO | Sale | 15,151 | $593.46 | $9M | Form 4 |
| Nov 26, 2025 | August J. Troendle | CEO | Sale | 41,331 | $606.88 | $25.1M | Form 4 |
| Nov 25, 2025 | August J. Troendle | CEO | Sale | 42,392 | $615.52 | $26.1M | Form 4 |
| Nov 24, 2025 | August J. Troendle | CEO | Sale | 59,025 | $607.78 | $35.9M | Form 4 |
| Nov 24, 2025 | Susan E Burwig | Vice president | Sale | 20,000 | $609.15 | $12.2M | Form 4 |
| Nov 21, 2025 | Kevin M. Brady | CFO | Sale | 3,000 | $590.35 | $1.8M | Form 4 |
| Nov 21, 2025 | August J. Troendle | CEO | Sale | 21,858 | $592.18 | $12.9M | Form 4 |
| Nov 20, 2025 | August J. Troendle | CEO | Sale | 6,830 | $598.49 | $4.1M | Form 4 |
| Nov 19, 2025 | August J. Troendle | CEO | Sale | 23,862 | $592.07 | $14.1M | Form 4 |
| Nov 18, 2025 | August J. Troendle | CEO | Sale | 7,191 | $590.84 | $4.2M | Form 4 |
| Nov 17, 2025 | August J. Troendle | CEO | Sale | 6,047 | $591.00 | $3.6M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| August J. Troendle | CEO, Director, 10% owner | – | $343M | Sep 30, 2026 |
| Susan E Burwig | Exec. VP, Operations | – | $30.2M | Oct 27, 2026 |
| Jesse J Geiger | President | – | $14.4M | Mar 17, 2026 |
| Stephen P Ewald | General Counsel & Corp. Secy. | – | $8.2M | Oct 29, 2026 |
| Fred B Davenport Jr | Director | – | $4.4M | Aug 19, 2026 |
| Kevin M. Brady | CFO & Treasurer | – | $3.9M | Aug 20, 2026 |
| Brian T Carley | Director | – | $3M | Aug 19, 2026 |
| Robert O. Kraft | Director | – | $2.4M | Aug 26, 2026 |
| Cornelius P. McCarthy III | Director | – | $1.2M | Aug 11, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
MEDP short interest
Low short interest. 4.9% of MEDP shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went down 27%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.38M MEDP shares were sold short, 4.9% of the shares outstanding, down 14.1% from the report before. At the average daily volume of 399,615 shares, buying them all back would take about 3.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.38M | 4.95% | -14% | 399,615 | 3.5 |
| Oct 15, 2026 | 1.61M | 5.78% | +1% | 244,805 | 6.6 |
| Sep 30, 2026 | 1.60M | 5.72% | -5% | 275,442 | 5.8 |
| Sep 15, 2026 | 1.69M | 6.04% | +1% | 191,014 | 8.8 |
| Aug 31, 2026 | 1.67M | 5.99% | +6% | 203,138 | 8.2 |
| Aug 14, 2026 | 1.58M | 5.66% | -10% | 206,622 | 7.6 |
| Jul 31, 2026 | 1.75M | 6.26% | -20% | 457,885 | 3.8 |
| Jul 15, 2026 | 2.19M | 7.67% | +3% | 298,878 | 7.3 |
| Jun 30, 2026 | 2.13M | 7.44% | +2% | 362,748 | 5.9 |
| Jun 15, 2026 | 2.09M | 7.31% | +2% | 248,477 | 8.4 |
| May 29, 2026 | 2.05M | 7.20% | +8% | 307,030 | 6.7 |
| May 15, 2026 | 1.90M | 6.67% | +23% | 347,281 | 5.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded MEDP
Since Nov 17, 2024, 4 members of Congress reported 4 purchases and 7 sales of MEDP. The latest was a purchase by David J. Taylor on May 15, 2026, reported May 28, 2026.
Purchases 4Sales 7
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| May 15, 2026 | David J. Taylor (R-OH) | Purchase | $1K–$15K | Self | May 28, 2026 | Report |
| Feb 26, 2026 | David J. Taylor (R-OH) | Purchase | $1K–$15K | Self | Mar 6, 2026 | Report |
| Jan 29, 2026 | David J. Taylor (R-OH) | Purchase | $1K–$15K | Self | Feb 2, 2026 | Report |
| Jan 16, 2026 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Feb 2, 2026 | Report |
| Jan 15, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Sale | $15K–$50K | Self | Feb 13, 2026 | Report |
| Oct 9, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Nov 18, 2025 | Report |
| Aug 4, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Sep 12, 2025 | Report |
| Jul 24, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Partial sale | $1K–$15K | Self | Aug 14, 2025 | Report |
| Jul 23, 2025 | David J. Taylor (R-OH) | Sale | $1K–$15K | Self | Sep 2, 2025 | Report |
| Jul 22, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jan 13, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Joint | Feb 13, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Medpace Holdings company events
Medpace Holdings filed 6 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Oct 21, 2026.
- Oct 21, 2026AnnouncementThe Company’s Board of Directors terminated the Company’s current stock repurchase authorization of the Company’s common stock, $0.01 par value which was set to expire on December 31, 2026. Filing
- Jul 22, 2026ResultsReleased financial results. Filing
- Jun 4, 2026LeadershipMedpace Holdings, Inc. appointed Brad W. Hansman, age 43, to the position of Executive Vice President, Operations. Filing
- May 19, 2026VoteReported shareholder vote results. Filing
- Apr 22, 2026LeadershipJesse Geiger notified the Company of his intent to resign as President and that he will retire from the Company effective May 31, 2026. Filing
- Feb 9, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Medpace Holdings financials
Famous investors that hold MEDP
9 of the 50 well-known investors we track reported holding MEDP in their latest 13F filing. The largest position is Jim Simons's, worth $282M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 452,428 | $282M | 0.4% | +9% |
| Ken Fisher · Fisher Asset Management | Q3 2026 | 130,522 | $81.5M | 0.0% | -0% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 103,659 | $64.7M | 0.0% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 57,506 | $35.9M | 0.2% | +269% |
| Israel Englander · Millennium Management | Q3 2026 | 38,775 | $24.2M | 0.0% | New |
| Jeremy Grantham · GMO | Q3 2026 | 34,366 | $21.5M | 0.0% | +1% |
| Terry Smith · Fundsmith | Q3 2026 | 25,940 | $16.2M | 0.1% | -50% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 15,812 | $9.9M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 846 | $528K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 4 filings named MEDP in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 4.1% |
| Nov 16, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 4.1% |
| Nov 13, 2026 | AQR Capital Management, LLC | 13G | 5.0% |
| Nov 13, 2026 | AQR Capital Management, LLC | 13G | 5.0% |
Questions about Medpace Holdings, Inc. (MEDP) stock
Who owns the most MEDP stock?
The largest reported owner of Medpace Holdings, Inc. (MEDP) is BlackRock, Inc., with 8.7% of the company. In total, 695 funds and institutions reported holding MEDP at the end of Q2 2026, together about 87% of the shares. See the largest owners.
Are MEDP insiders buying or selling?
In the last 12 months, MEDP insiders reported no open-market purchases and 50 sales worth $411M. The latest trade was on Oct 29, 2026. See every trade.
What is the short interest in MEDP?
As of Oct 30, 2026, 1.38M MEDP shares were sold short, 4.9% of the shares outstanding, down 14.1% from the report before. At the average daily volume of 399,615 shares, buying them all back would take about 3.5 trading days (days to cover). See the history.
Have members of Congress traded MEDP?
Yes. 4 members of Congress reported 4 purchases and 7 sales of MEDP since Nov 17, 2024. The latest was reported on May 28, 2026. See the trades.
Which famous investors hold MEDP?
9 of the 50 well-known investors we track reported MEDP in their latest 13F filing, including Jim Simons, Ken Fisher, Ken Griffin. The largest position is worth $282M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.